NIH SBIR Phase I (Omnibus)
Funds United States small businesses advancing biomedical and behavioral-health innovations through early technical validation.
The NIH SBIR Phase I Omnibus is the National Institutes of Health's flagship non-dilutive feasibility grant for U.S. small businesses working on biomedical, behavioral-health, or health-services innovation. Issued under activity code R43, Phase I awards are capped at $306,872 in total costs (direct costs, indirect costs, and a permitted profit fee of up to 7%) and are intended to fund six to twelv…
Any biomedical, behavioral, or health-services R&D aligned to the mission of one of NIH's 27 institutes and centers. Topic priorities are published by each IC; the omnibus parent NOFO is investigator-initiated within those priorities.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up